PDF File - The Indian Society for Parasitology

Malaria vaccine development29falciparum: a major role for IgG3 in antibody-dependent Thornton GB and Hill AVS. 2005. Safety, immunogenicitymonocyte-mediated cellular inhibition of parasite growth in and efficacy of a pre-erythrocytic malaria candidatevitro. Exp Parasitol 98: 20-28.vaccine, ICC-1132 formulated in Seppic ISA 720. VaccineTempleton TJ and Kaslow DC. 1999. Identification of23: 857-864.additional members define a Plasmodium falciparum gene Wang R, Charoenvit Y, Corradin G, Porozzi R, Hunter RL,superfamily which includes Pfs 48/45 and Pfs 230. Mol Glenn G, Alving CR, Church P and Hoffman SL. 1995.Biochem Parasitol 101: 223-227.Induction of protective polyclonal antibodies byimmunization with a Plasmodium yoelii circumsporozoiteTolle R, Fruh K, Doumbo O, Koita O, N'Diaye M, Fischer A,protein multiple antigen peptide vaccine. J Immunol 154:Dietz K and Bujard H. 1993. A prospective study of the2784-2793.association between the human humoral immune responseto Plasmodium falciparum blood stage antigen gp 190 and Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM,control of malaria infections. Infect Immun 61: 40-47.Charoenvit Y, Jones TR, Hobart P, Margalith M, Ng J, WeissWR, Sedegah M, de Taisne C, Norman JA and Hoffman SL.Trucco C, Fernandez-Reyes D, Howell S, Stafford WH, Scott-1998. Induction of antigen-specific cytotoxic TFinnigan TJ, Grainger M, Ogun SA, Taylor WR and Holderlymphocytes in humans by a malaria DNA vaccine. ScienceAA. 2001. The Mz surface protein 6 gene codes for a 36 kDa282: 476-480.protein associated with the Plasmodium falciparum Mzsurface protein-1 complex. Mol Biochem Parasitol 112: 91- Webster DP, Dunachie S, Vuola JM, Berthoud T, Keating S,101. Laidlaw SM, McConkey SJ, Poulton I, Andrews L,Andersen RF, Byon P, Butcher G, Sinden R, Skinner MA,Tsuji M and Zavala F. 2003. T cells as mediators of protectiveGilbert SC and Hill VS. 2005. Enhanced T cell mediatedimmunity against liver stages of Plasmodium. Trendsprotection against malaria in human challenges by using theParasitol 19: 88-93.recombinant poxviruses FP9 and modified vaccinia virusValero MV, Amador LR, Galindo C, Figuerao J, Bello MS, Ankara. Proc Natl Acad Sci USA 102: 4836-4841.Murillo LA, Mora AL, Patarroyo G, Rocha CL, Rojas M,Weisman S, Wang L, Billman-Jacobe H, Nhan DH, Richie TLAponte JJ, Sarmiento LE, Losada DM, Coronell CG, Ortegaand Coppel RL. 2001. Antibody responses to infections withNM, Rosas JE, Alonso PL and Patarroyo ME. 1993.strains of Plasmodium falciparum expressing diverse formsVaccination with SPf66, a chemically synthesised vaccine.of Mz surface protein 2. Infect Immun 69: 959-967.against Plasmodium falciparum malaria in Colombo.Lancet 341: 705-710.Welch WH. 1897. Malaria: Definitions, Synonyms, history andparasitology. In: Loomis & Thompson's Syst. Pract Med 1:Vukovic P, Chen K, Qin Liu X, Foley M, Boyd A, Kaslow D and17.Good MF. 2003. Single-chain antibodies produced by phagedisplay against the C-terminal 19 kDa region of Mz surface Wipasa J, Xu H, Makobongo M, Gatton M, Stowers A and Goodprotein-1 of Plasmodium yoelii reduce parasite growth MF. 2002. Nature and specificity of the required protectivefollowing challenge. Vaccine 20: 2826-2835.immune response that develops post challenge in micevaccinated with the 19-kilodalton fragment of P. yoelii MzVukovic P, Hogarth PM, Barnes N, Kaslow DC and Good MF.surface protein 1. Infect Immun 70: 6013-6020.2000. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium Yazdani SS, Shakri AR, Mukherjee P, Baniwal SK and Chitnisyoelii Mz surface protein 1 transfer protection to mice CE. 2005. Evaluation of immune responses elicited in micedeficient in Fc-ãRI receptors. Infect Immun 68: 3019-3022. against a recombinant malaria vaccine based onPlasmodium vivax duffy binding protein. Vaccine 22: 3727-Walther M, Dunachie S, Keating S, Vuola JM, Berthoud T,3737.Schmidt A, Maier C, Andrews L, Andersen RF, Gilbert S,Poulton I, Webster D, Dubovsky F, Tierney E, Sarpotdar P,Correa S, Huntcooke A, Butcher G, Williams J, Sinden RE,